DEVON MOSER: Open Payments
NPI 1063912202 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,264 in 123 payments from 22 companies in 2025. Trend: 2023 $2,910 · 2024 $2,233 · 2025 $3,264
Food & beverage: $3,230Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $705 |
| CSL Behring | 12 | $321 |
| Regeneron Healthcare Solutions, Inc. | 13 | $296 |
| Grifols USA, LLC | 13 | $258 |
| Novartis Pharmaceuticals Corporation | 18 | $203 |
| Blueprint Medicines Corporation | 5 | $194 |
| GlaxoSmithKline, LLC. | 9 | $188 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $176 |
| GENZYME CORPORATION | 5 | $160 |
| Genentech USA, Inc. | 6 | $154 |
Products named: DUPIXENT, TEZSPIRE, Prolastin-C Liquid, AIRSUPRA, XOLAIR, AYVAKIT, Andembry, NEFFY.
Industry payments across ID — which companies pay providers there.
